Evidence map›Paper›PMID 41407538›Full record

ArticleClinical and translational medicine2025

Single-cell transcriptome analyses reveal disturbed decidual microenvironment in women of advanced maternal age.

Hongliang Xie, Yu Lu, Aolin Zhang, Anqi Zheng, Baofeng Rao, Cuiyu Yang, Anyao Li, Wenbo Guo, Linhua Hu, Xiaoling Huang and 4 more

Abstract read
In one paragraph

Article in Clinical and translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Hongliang XieCollege of Pharmaceutical Sciences & Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Yu LuCollege of Pharmaceutical Sciences & Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Aolin ZhangCollege of Pharmaceutical Sciences & Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Anqi ZhengCollege of Pharmaceutical Sciences & Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Baofeng RaoCollege of Pharmaceutical Sciences & Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Cuiyu YangAssisted Reproduction Unit, Department of Obstetrics and Gynecology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Anyao LiCollege of Pharmaceutical Sciences & Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Wenbo GuoCollege of Pharmaceutical Sciences & Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Linhua HuDepartment of Nursing, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Xiaoling HuangDepartment of Nursing, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Chi Chiu WangDepartment of Obstetrics and Gynaecology, Li Ka Shing Institute of Health Sciences, School of Biomedical Sciences, and Sichuan University-Chinese University of Hong Kong Joint Reproductive Medicine Laboratory, The Chinese University of Hong Kong, Hong Kong, China.
Songying ZhangAssisted Reproduction Unit, Department of Obstetrics and Gynecology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.ORCID 0000-0001-8044-6237
Xiaohui FanCollege of Pharmaceutical Sciences & Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, China.ORCID 0000-0002-6336-3007
Lu LiCollege of Pharmaceutical Sciences & Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, China.ORCID 0009-0004-0588-8763

Funding

Health and Medicinal Research Fund from Health Burden, HKSAR 15160971 Chi Chiu WangHigh-level Talents Special Support Program of Zhejiang Province 2024-KYY-GXJS-0026 Lu LiNational Key Research and Development Program of China 2023YFC3504600 Lu Li"Pioneer" and "Leading Goose" R&D Program of Zhejiang 2025C02123 Cuiyu Yang'Pioneer' R&D Program of Zhejiang 2024C03106 Xiaohui FanStarlit South Lake Leading Elite Program 2023C303007 Xiaohui FanTheme-based Research Scheme, Research Grants Committee T13-602/21-N Chi Chiu WangTransverse Research Project of Zhejiang University 2023-KYY-A070350007 Lu LiZhejiang Province Traditional Chinese Medicine Science and Technology Project GZY-ZJKJ-24076 Lu Li
6 · The paper itself

Abstract

backgroundAdvanced maternal age (AMA) increases pregnancy risk. However, uterine-specific mechanisms independent of oocyte and embryo quality remain poorly defined. This study aimed to characterise the decidual microenvironment in women with AMA to identify key pathological changes and regulatory pathways. METHODS AND

resultsThrough integrated histology, organoid modelling, and high-resolution scRNA-seq of first-trimester decidua from women of AMA and controlled reproductive age, we uncovered a pathologically remodelled decidual microenvironment characterised by aberrant cellular states and pathological differentiation pathways, leading to a pro-fibrotic state and accompanied by immune cell dysfunction, and disrupted intercellular communication in the AMA decidua. Central to this pathology was hyperactivated TGF-β signalling, driving fibroblast-to-myofibroblast transition and extracellular matrix overproduction, thereby fuelling fibrosis. Aberrant TGF-β further impaired decidual stromal cell (DSC) differentiation, leading to the failure of the essential mesenchymal-to-epithelial transition. We identified PRR15 as a novel DSC-specific regulator that is markedly suppressed in AMA. PRR15 deficiency unleashed hyperactive TGF-β/SMAD signalling, directly causing decidualisation failure, enhanced fibrosis, and aborted DSC differentiation. Epithelial-mesenchymal transition and immune cell reprogramming towards pro-fibrotic transcriptional signatures further amplify the fibrotic pathology.

conclusionThis study established the aged decidual microenvironment, orchestrated by dysregulated TGF-β signalling and PRR15 loss, as a critical independent determinant of reproductive failure in AMA. Thus, it unveils novel diagnostic and therapeutic targets and strategies. KEY POINTS: We provide the first single-cell atlas of the human decidua in advanced maternal age (AMA). A novel PRR15-TGF-β axis is identified, where PRR15 loss drives stromal fibrosis and decidualisation failure. This study reveals that AMA-associated uterine fibrosis begins in the first trimester, shifting focus to maternal factors.

Indexed as

Cellular MicroenvironmentDeciduaMaternal AgeSingle-Cell AnalysisAdultAdvanced Maternal AgeFemaleGene Expression ProfilingHumansPregnancySingle-Cell Gene Expression AnalysisTranscriptomeTransforming Growth Factor betaTransforming Growth Factor betaadvanced maternal age, decidualisationdecidua fibrosis, epithelial–mesenchymal transition, fibroblast–myofibroblast transition, PRR15‐TGF‐β axis, single cell RNA sequencing

Identifiers

PMID41407538
PMCPMC12711380

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.